MedDataX Logo

Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access

NCT ID: NCT07208071

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access for peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vascular Access

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Augmented reality ultrasound-guided vascular access

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

Providers will not use augmented reality assistance when performing ultrasound-guided vascular access for this arm of the study

Group Type NO_INTERVENTION

No interventions assigned to this group

AR Arm

Providers will use augmented reality assistance when obtaining ultrasound-guided vascular access

Group Type EXPERIMENTAL

Augmented reality headset use

Intervention Type OTHER

Use of a Microsoft HoloLens 2 headset with augmented reality assistance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Augmented reality headset use

Use of a Microsoft HoloLens 2 headset with augmented reality assistance

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient requiring ultrasound-guided vascular access

Exclusion Criteria

* Age less than 5 years old
* Need for urgent vascular access
Minimum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeffrey Coote

Pediatric Critical Care Fellow

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeffrey Coote Principal Investigator, MD

Role: CONTACT

Phone: 5044817903

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Saruwatari MS, Nguyen TN, Talari HF, Matisoff AJ, Sharma KV, Donoho KG, Basu S, Dwivedi P, Bost JE, Shekhar R. Assessing the Effect of Augmented Reality on Procedural Outcomes During Ultrasound-Guided Vascular Access. Ultrasound Med Biol. 2023 Nov;49(11):2346-2353. doi: 10.1016/j.ultrasmedbio.2023.07.011. Epub 2023 Aug 11.

Reference Type RESULT
PMID: 37573178 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UAB

Identifier Type: OTHER

Identifier Source: secondary_id

IRB-300014090

Identifier Type: -

Identifier Source: org_study_id